Results 271 to 280 of about 458,398 (305)
Some of the next articles are maybe not open access.
Hepatitis B Virus Infection and Cyclophosphamide
Annals of Internal Medicine, 1982Excerpt To the editor: We read with interest the paper of Hoofnagle and associates (1) on clearance of hepatitis B surface antigen (HBsAg) after reactivation of hepatitis B virus (HBV) chronic infe...
CHIARAMONTE, MARIA +4 more
openaire +2 more sources
Immunopathology of Hepatitis B Virus Infection
International Reviews of Immunology, 2008The interaction between immune responses and hepatitis B virus (HBV) is coordinated between innate and adaptive immunity. Anti-HBs antibodies protect the host by blocking the binding ability of HBV. Anti-HBc antibodies are detected with persistent HBV infection.
Hsiu-Ting, Tsai +3 more
openaire +2 more sources
Management of Hepatitis B Virus Infection
Gastroenterology Nursing, 2010An estimated 2 million people are living with chronic hepatitis B virus (CHBV) in the United States and are at risk for long-term consequences such as cirrhosis, liver decompensation, and hepatocellular carcinoma. Less than 10 years ago, there was no treatment of CHBV infection, but now, new drugs have recently been approved and there is considerable ...
Haeok, Lee +3 more
openaire +2 more sources
Occult hepatitis B virus infection
Journal of Hepatology, 2007The persistence of hepatitis B virus (HBV) genomes in HBV surface antigen (HBsAg) negative individuals is termed occult HBV infection. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays, but more frequently it is due to a strong suppression of viral replication and gene expression.
RAIMONDO, Giovanni +3 more
openaire +3 more sources
Immunopathogenesis of hepatitis B virus infection
Immunology & Cell Biology, 2006Hepatitis B virus (HBV) infection is a non‐cytopathic hepatotropic virus that can lead to severe liver disease including acute hepatitis, cirrhosis and hepatocellular carcinoma. Successful clearance of the virus as well as the establishment of liver disease is largely driven by a complex interaction between the virus and the host immune response.
J Judy, Chang, Sharon R, Lewin
openaire +2 more sources
Dynamics of hepatitis B virus infection
Microbes and Infection, 2002Mathematical models of the dynamics of HIV and hepatitis C virus infection have proven to be of great utility in understanding pathogenesis and designing better treatments. Here, we review the state of the art in modeling and interpreting data obtained from hepatitis B virus infected patients treated with antiviral agents.
Ruy M, Ribeiro +2 more
openaire +2 more sources
The Infant and Hepatitis B Virus Infection
Advances in Pediatrics, 1977HBV has been shown to be responsible for a broad spectrum of disease in infants although most are asymptomatic carriers with mild transaminase elevation and unresolved hepatitis on liver biopsy. Maternal-infant transmission is responsible for most infections. Blood product infusion should become less significant.
openaire +2 more sources
Hepatitis B virus infection and pregnancy
Clinics and Research in Hepatology and Gastroenterology, 2011Pregnancy only mildly affects that natural progression of acute and chronic infection by the hepatitis B virus (HBV) but it does bring to light three important questions. Mother to child (vertical) transmission risk is best prevented by mandatory HBs antigen testing in all pregnant women in their second trimester and by systemic serovaccination of ...
Stanislas, Pol +2 more
openaire +2 more sources
Chronic Hepatitis B Virus Infection
Medical Clinics of North America, 2014All providers, regardless of specialty, should perform screening for HBV on high-risk persons, especially those born in endemic countries. The primary care physician can perform the initial evaluation and follow-up of patients with chronic HBV by following the algorithm in this article and consulting with specialists when appropriate.
openaire +2 more sources
Hepatitis B virus infection in children
Expert Review of Anti-infective Therapy, 2015For two decades, hepatitis B vaccine has been integrated into national routine childhood vaccination programs in almost all countries. The prevalence of HBsAg has decreased in children worldwide. However, there are children who miss the benefit of hepatitis B vaccine in some regions and countries.
Haruki, Komatsu, Ayano, Inui
openaire +2 more sources

